Phibro Animal Health (PAHC) Cash from Investing Activities (2013 - 2026)

Phibro Animal Health's Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$16.8 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 7.92% year-over-year to -$16.8 million in Q1 2026; TTM through Mar 2026 was -$62.0 million, a 78.66% increase from a year earlier, with the FY2025 full-year figure at -$288.7 million, down 499.01% from the prior year.
• Cash from Investing Activities rose to -$16.8 million in Q1 2026 per PAHC's latest filing, from -$17.2 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $1.1 million in Q1 2024 and bottomed at -$260.5 million in Q4 2024.
• The 5-year median for Cash from Investing Activities is -$15.4 million (2023), against an average of -$28.6 million.
• Across the five-year window, Cash from Investing Activities jumped 102.99% in 2024 and tumbled 1715.13% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$9.8 million in 2022, then slumped by 153.43% to -$24.9 million in 2023, then slumped by 947.72% to -$260.5 million in 2024, then jumped by 93.4% to -$17.2 million in 2025, then climbed by 2.2% to -$16.8 million in 2026.
• Per Business Quant, the three latest PAHC Cash from Investing Activities figures stand at -$16.8 million (Q1 2026), -$17.2 million (Q4 2025), and -$21.0 million (Q3 2025).